Fundraising Fox
/Companies
Sign in

Lighthouse Pharma

Novato, US · Founded 2022 · 4 known investors

Find your way into Lighthouse Pharma

Each arrow is one introduction. Sign up to fill in the first one.

52 people can intro you to Casey

Ask Gary Lauder to introduce you to Casey Lynch

You →Gary · together at Alzheimer's Drug Discovery Foundation →Casey

Sign up to find every way you can get introduced to Lighthouse Pharma

  • Your email: who you already know at Lighthouse Pharma, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Lighthouse Pharma team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

Lighthouse Pharmaceuticals develops precision therapeutics for major unmet medical needs, with a lead program (LHP588), a gingipain inhibitor being tested in the Phase 2 SPRING trial for P. gingivalis-positive Alzheimer's disease. The company works in the biotechnology and drug development space, using patient responder analyses and dose modeling to advance its clinical candidates.

BiotechLongevity

Founders & leadership

Lighthouse Pharma was founded in 2022 by Casey Lynch.

CLCasey Lynch
Casey LynchChief Executive Officer, Director, & Co-founderCasey Lynch has held executive roles including public company CEO and currently serves as an officer and director at Lighthouse Pharmaceuticals, with experience in pharmaceutical development, capital raising, and translational research.
SD
Stephen DominyNamed on SEC filing

Board

CMCampbell Murray
Campbell MurrayDirectorAdvisor

Investors · 4

Portfolialisted by PortfoliaSan Mateo

How we know: Portfolia's portfolio page · the VCSheet dataset · Not right? Tell us

Marin Sonoma Impact VenturesreportedCorte Madera

How we know: funding news · press coverage · Not right? Tell us

Also in the syndicate · 1

Double Point Ventureslead

Reported raises · per SEC filings

Form D private placements

$15.2M disclosed across 1 round · 2026

▶$15.2MraisedMay 2026 · 25 investors · Other
Rule 506(b)
Officers, directors & promoters on the filing
  • Campbell MurrayDirector
  • Stephen DominyDirector
  • Casey LynchExecutive Officer, Director, Promoter
Offering amount
$15.2M
Amount sold
$15.2M
First sale
Apr 2026
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Lighthouse Pharma do?
Lighthouse Pharmaceuticals develops precision therapeutics for major unmet medical needs, with a lead program (LHP588), a gingipain inhibitor being tested in the Phase 2 SPRING trial for P. gingivalis-positive Alzheimer's disease. The company works in the biotechnology and drug development space, using patient responder analyses and dose modeling to advance its clinical candidates.
Who founded Lighthouse Pharma?
Lighthouse Pharma was founded by Casey Lynch in 2022.
Who are Lighthouse Pharma's investors?
Lighthouse Pharma's investors include MSIV, Portfolia, Marin Sonoma Impact Ventures.
How much funding has Lighthouse Pharma raised?
Lighthouse Pharma has disclosed $15.2M raised across 1 round.
Where is Lighthouse Pharma headquartered?
Lighthouse Pharma is headquartered in Novato, US.